Sprout Pharmaceuticals will resubmit flibanserin for FDA approval

February 20, 2015 2:00 PM

62 0

Sprout Pharmaceuticals will resubmit flibanserin for FDA approval

This week, Sprout Pharmaceuticals made an announcement that it will be resubmitting its female sex drug, flibanserin, for the U. S. FDA approval. If the drug secures FDA approval, it will be the first of its kind for women in the United States to treat female hypoactive sexual disorder, or a low sex drive.

Over a dozen drugs are already available in the US, which deal with some kind of sexual dysfunction. However, since Viagra's little blue pill is available; almost all of the approved sex drugs are manufactured for men. Such drugs for women didn't hit the market despite the report that almost half of...

Also read: Italy, eurozone, can handle PM Renzi's resignation -Moscovici

Read more

To category page

Loading...